Last Thursday, the FDA gave full approval to the first drug intended to treat COVID-19, but a recent Vox article suggests they may have put the cart ahead of the horse. Remdesivir is an antiviral drug developed by Gilead Sciences, and is marketed under the brand Veklury. It had previously received emergency use authorization back in May for severe COVID cases, and was allowed to be used on less serious cases when the FDA relaxed its guidelines in August.
Should the FDA Have Approved Remdesivir?
Researchers question the validity of the FDA’s first approved COVID-19 drug.
Oct 30, 2020
Recommended
Recommended
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Sustainable Healthcare Packaging Solutions That Work
Industry leaders share proven strategies for reducing packaging emissions by up to 70% while meeting safety and regulatory requirements.
Read More
Downloads
